The Saudi Food and Drug Authority (SFDA) has identified an advertisement that violates regulations by making exaggerated and inaccurate assertions about a medical device. The device in question is meant to alleviate pain and enhance joint performance for patients suffering from mild osteoarthritis. However, the promotional material did not comply with established rules governing medical device advertising.
Following the discovery, the SFDA initiated legal proceedings against the responsible firm, and competent authorities shut down the associated healthcare facility. Additionally, the advertiser was referred to the appropriate bodies for further legal action.
According to the SFDA, such infractions fall under the Medical Devices and Supplies Law and its Implementing Regulations. Violators can face severe penalties, including a maximum fine of SR5 million, a temporary suspension of activities and facility closure for up to 180 days, and the potential revocation of their operating license.
The authority has encouraged members of the public to report any violations by calling the unified number, 19999. It also urged individuals to confirm medical claims through official channels before making healthcare and treatment choices.
